Laboratory Products 81
Versatile Mixer Mill with User-Friendly Features
Innovative Staining Solution for
Enhanced Diagnostics Effi ciency Leica Biosystems has introduced BOND-PRIME, a highly advanced and faster staining solution in the European market. BOND-PRIME offers a comprehensive Universal Access feature that allows it to process any slide, using any reagent, at any time, and in any combination.
With the ability to provide diagnoses quickly, Single or STAT slides can now be processed and completed within an hour, making it especially vital for patients requiring urgent diagnostic decisions. Additionally, the turnaround time (TAT) for the average immunohistochemistry (IHC) slide has been reduced to an average of 90 minutes, allowing for 100% instrument utilisation without the need for constant monitoring or attention.
With the new Mixer Mill MM 400 Retsch has developed an extremely versatile bench-top unit which combines easy and safe handling with maximum fl exibility for your sample preparation process. It is used for dry, wet and cryogenic grinding of small sample volumes up to 2 x 20 ml.
The MM 400 covers a huge range of applications: from mixing and pulverising to cell disruption for DNA/ RNA- and protein extraction and mechanochemical processes.
New features include storage of 12 SOPs and 6 program cycles, a maximum grinding time of 99 hours and the possibility to calibrate time and frequency. This is particularly helpful to ensure highest possible reproducibility and consistent results, as required, for example, in the pharmaceutical industry.
The MM 400 is operated with grinding jars that are available in 7 materials and 6 sizes, including transparent PMMA jars for in-situ Raman spectroscopy, and a range of adapters for single-use vials from 0.2 ml to 50 ml.
The scope of typical sample materials is impressive. The MM 400 is employed in areas like agriculture, biology, chemistry, environment, food, geology, metallurgy, ceramics, pharmaceuticals, to name but a few.
More information online:
ilmt.co/PL/BK3m
60285pr @
reply-direct.com
The BOND-PRIME staining platform seamlessly adjusts and streamlines the staining workfl ow to ensure that every slide is optimally stained, without any staining position left unutilised. This innovative solution offers an impressive capacity of 70 open-access reagent positions and can handle up to 72 slides on-board.
“In today’s fast-paced health care environment, adaptability is essential to ensure that slides are processed in a timely manner, without compromising on quality,” explained Colin White, Senior Vice President of Advanced Staining, and Imaging.
“BOND-PRIME is a generation ahead. It enables labs to achieve a high-speed, continuous workfl ow, an average single slide TAT of 90 minutes, no downtime and minimal need for manual intervention. The impact on quality and productivity is truly impressive.”
Apart from its adaptability and speed, the platform also integrates novel technology that further elevates the quality of staining available to laboratories. The system leverages this cutting-edge technology to produce consistently crisp, clear stains, while being gentle on sample tissues and minimising carry-over. To achieve this, Leica Biosystems created Active Reagent Control (ARC), which enables highly controlled reagent application and incubation.
“We have a history of innovation that addresses specifi c customer needs,” said Gustavo Perez- Fernandez, President at Leica Biosystems. “The BOND-PRIME staining solution presents a quantifi able benefi t to mid-sized and large laboratories in terms of both quality and greater effi ciency. STAT cases can be processed quickly and effi ciently, without holding back the validation of more routine cases. By streamlining workfl ow, the use of BOND-PRIME ensures that fewer cases overall are left pending.”
The BOND-PRIME staining solution is currently available in select countries within the EMEA region, as well as in the United States, Canada, Australia, and New Zealand.
More information online:
ilmt.co/PL/JQjb 60322pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188
